• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA renews Syapse collaboration to use real-world data in oncology

cafead

Administrator
Staff member
  • cafead   Dec 06, 2023 at 09:02: PM
via The US Food and Drug Administration (FDA) has renewed a four-year collaboration agreement between its Oncology Center of Excellence and Syapse, a real-world-data-focused healthcare company.

article source